๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study

โœ Scribed by Postmus, Pieter E.; Mulder, Nanno H.; De Vries-Hospers, Hilly G.; Mulder, Paula O.M.; Maas, Annelies; Meinesz, Aaf F.; Sleijfer, Dirk Th.; De Vries, Elisabeth G.E.

Book ID
123134922
Publisher
Elsevier Science
Year
1985
Weight
411 KB
Volume
21
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High-dose cyclophosphamide and VP 16 as
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung
โœ David Cunningham; Stephen W. Banham; Andrew H. Hutcheon; Alistair Dorward; Salim ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 400 KB

This study investigated the use of late dose intensification therapy (LDIT) with cyclophosphamide (180 mg/kg) and VP 16 (1 g/m2) plus autologous bone marrow rescue in 22 patients with small cell lung cancer (SCLC). These patients were selected from a group of 95 patients who received three courses o